Effect of Riociguat on Bone Metabolism

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

March 31, 2009

Primary Completion Date

December 31, 2009

Study Completion Date

July 31, 2010

Conditions

Pharmacology, Clinical

Interventions

DRUG

Riociguat (Adempas, BAY63-2521) immediate release tablet of 2.5 mg

Riociguat administered in a dose of 2.5 mg (single tablet), thrice daily, over 14 days.

DRUG

Placebo

Placebo administered as a single tablet, thrice daily, over 14 days.

Trial Locations (1)

Cologne